City Research Online

Abstract

The paper strives to participate in the academic debate of whether the Coronavirus Disease 2019 (“COVID-19”) patent waiver is the answer to solving the calamities caused by the pandemic. We recognise vaccine inequality to lie at the core of the issues caused by the pandemic. Moreover, we argue that although patent law's protectionist nature can lead to the assumption that patent law is the problem, patents play a minor role in the inaccessibility of the COVID-19 vaccines. The way the vaccine market operates means that technical assistance is necessary to boost production and accessibility that requires a cross-disciplinary approach. As a solution to this, instead of a COVID-19 waiver to rectify vaccine inequality, we push for solutions of a more compulsory nature.

Publication Type:	Monograph (Working Paper)
Additional Information:	Copyright, 2023, the authors.
Publisher Keywords:	Patent, Law, COVID-19, Waiver, Pandemic
Subjects:	H Social Sciences > HN Social history and conditions. Social problems. Social reform Q Science > QR Microbiology > QR180 Immunology R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine R Medicine > RC Internal medicine
Departments:	The City Law School > Academic Programmes The City Law School > CLS Working Paper Series

Export

Downloads